RecruitingNot ApplicableNCT06115031

Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients

Effect of Remimazolam Versus Propofol Anesthesia on Postoperative Delirium in Neurosurgical Patients: A Randomised, Controlled, Noninferiority Trial


Sponsor

Samsung Medical Center

Enrollment

696 participants

Start Date

Jan 29, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The investigator aimed to evaluate the incidence of postoperative delirium after remimazolam-based total intravenous anestheisa (TIVA) compared to the propofol-based TIVA in patients undergoing neurosurgery.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Propofol and a drug called Remimazolam for people with postoperative delirium. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRemimazolam

General anesthesia will be induced and maintained using continuous infusion of intravenous remimazolam.

DRUGPropofol

General anesthesia will be induced and maintained using target-controlled infusion of intravenous propofol.


Locations(1)

Samsung Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06115031


Related Trials